Maria Vittoria Barbarossa, PhD (she/her/hers)

Senior Pharmacometrician
Abbvie, Germany

Poster(s):

• (S-056) Quantitative Assessment of Glecaprevir and Pibrentasvir Exposures in Adults with Chronic or Acute HCV Infection: A Comprehensive Analysis of Phase 2 and 3 Studies Utilizing Subject Matching and Population PK Simulations
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT